Profil
Michael H.
McInaw formerly worked at Aevi Genomic Medicine, Inc., as Chief Financial Officer & Controller from 2019 to 2020.
Mr. McInaw received his undergraduate degree and Masters Business Admin degree from St. Joseph's University.
Anciens postes connus de Michael H. McInaw
| Sociétés | Poste | Fin |
|---|---|---|
| AEVI GENOMIC MEDICINE, INC. | Directeur Financier/CFO | 03/02/2020 |
Formation de Michael H. McInaw
| St. Joseph's University | Masters Business Admin |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 1 |
|---|---|
Aevi Genomic Medicine, Inc.
 Aevi Genomic Medicine, Inc. Pharmaceuticals: MajorHealth Technology Aevi Genomic Medicine, Inc. is a clinical stage biopharmaceutical company, which engaged in the discovery of treatments for rare and orphan diseases. Its research and development efforts leverage an internal genomics platform and an ongoing collaboration with the Center for Applied Genomics (CAG) at The Children's Hospital of Philadelphia (CHOP). The company was founded by Andrew Leonard Pearlman on January 27, 2000 and is headquartered in Wayne, PA. | Health Technology |
